 Inhibition of SREBP by betulin decreased the biosynthesis of cholesterol and fatty acids.In vivo, betulin ameliorated diet-induced obesity, decreased the lipid contents in serum and tissues, and increased insulin sensitivity.Furthermore, betulin reduced the size and improved the stability of atherosclerotic plaques.